In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...

The vaccine will only be available to those at high risk from Covid—excluding those who may need it to protect a relative or ...

Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.

Secretary Robert F. Kennedy Jr., who leads the Department of Health and Human Services, will soon announce the changes to the ...

Novavax (NVAX) stock in focus as the U.S. FDA approves its COVID-19 vaccine Nuvaxovid for high-risk groups in the U.S. Read ...

Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...

Singapore sees a rise in COVID-19 cases, reaching 14,200 in a week. This increase is due to waning immunity and new variants.

According to health authorities, the increase in infections are likely because of waning population level immunity to the ...